Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

brain_scan_small

Newron and Zambon to collaborate on Parkinson’s dyskinesia drug trial

March 15, 2021 Sales and Marketing Newron Pharmaceuticals, Parkinson's, Zambon

Newron Pharmaceuticals and its partner Zambon have announced an agreement for a potentially pivotal study to evaluate the efficacy of …
News
Roche building

Roche acquire GenMark in $1.8 billion deal

March 15, 2021 Sales and Marketing Diagnostics, GenMark, Roche

Pharmaceutical giant Roche have bought GenMark Diagnostics in a deal worth $1.8 billion, expanding their infectious disease testing for illnesses …
News
astrazeneca_sign_sky

Netherlands suspends AstraZeneca vaccine despite safety assurances

March 15, 2021 Medical Communications, Sales and Marketing AstraZeneca, COVID-19, EMA, EU, WHO

The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause …
News
libtayo

Phase III trial of Libtayo stopped early after positive overall survival results

March 15, 2021 Sales and Marketing Cancer, Libtayo, Regeneron, Sanofi

A Phase III trial of Sanofi and Regeneron’s PD-1 inhibitor Libtayo (cemiplimab) will be stopped early after positive results demonstrated …
News
credit_-_daniel_leal-olivas-afp

CHMP recommends Lilly’s bamlanivimab for COVID-19 patients

March 8, 2021 Sales and Marketing COVID-19, EMA, Eli Lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive scientific opinion for Eli Lilly’s bamlanivimab …
News
dw-anzcxqaqavhl

FDA grants Priority Review to Korsuva for CKD-associated pruritis

March 8, 2021 Sales and Marketing Cara Therapeutics, FDA, Korsuva

The FDA has accepted and granted Priority Review for the new drug application (NDA) for Cara Therapeutics’ Korsuva (difelikefalin) solution …
News

NICE recommends £1.79m gene therapy for spinal muscular atrophy in babies

March 8, 2021 Sales and Marketing NICE, spinal muscular atrophy

NICE is set to approve a new and potentially curative one-off gene therapy for babies with the rare genetic disorder …
News
landing-hero-images1

ViiV presents positive long-term data for combined HIV treatment

March 8, 2021 Sales and Marketing HIV, ViiV Healthcare

ViiV Healthcare has presented positive long-term data from its global Phase IIIb ATLAS-2M study of the first complete, long-acting regimen …
News
roche__tree

Roche voluntarily withdraws Tecentriq’s US bladder cancer indication

March 8, 2021 Sales and Marketing Cancer, Roche, bladder cancer, tecentriq

Roche has announced that the company is voluntarily withdrawing the US indication for Tecentriq (atezolizumab) in prior-platinum treated metastatic urothelial …
News

Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma

Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
Appointment
sophie_biguenet_cmo_abivax

Abivax appoints Dr Sophie Biguenet as Chief Medical Officer

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Appointment
Merck building

Merck and Debiopharm agree €898m deal to develop head and neck cancer treatments

March 1, 2021 Sales and Marketing Debiopharm, Merck, cancer treatment, head and neck cancer, xevinapant

German science and technology company Merck have agreed a worldwide in-licensing agreement with Debiopharm for the development and commercialisation of …
News

Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal

March 1, 2021 Sales and Marketing Cancer, Kazia, Oasmia

Oasmia Pharmaceutical, an innovation-focused specialty pharmaceutical company, is set to acquire exclusive global development rights for Kazia Therapeutics’ ovarian cancer …
News
Evotec building

Evotec and Chinook to partner on new kidney disease treatments

March 1, 2021 Sales and Marketing CKD, Chinook, Evotec, chronic kidney disease, kidney disease

Evotec and Chinook Therapeutics have agreed a deal to discover and develop new therapies for patients with chronic kidney diseases …
News

FDA approves Johnson & Johnson’s COVID-19 vaccine for emergency use

March 1, 2021 Sales and Marketing COVID-19, Janssen, Johnson & Johnson, vaccines

The FDA has issued emergency use authorisation for Johnson & Johnson’s one-shot COVID-19 vaccine, approving the jab for use in …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026